Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Checked against the public recordLast updated Nov 4, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Nucleix Ltd.
- Interventions being studied
- Procedure: Blood collection
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria - Cases: * Current or past smokers, with at least 20 pack-years * Subjects with either A high suspicion for lung cancer, with planned surgery to establish a definitive diagnosis within 60 days after date of blood collection OR treatment naive lung cancer patients Exclusion Criteria - Cases: * Known diagnosis or treatment of any previous cancer, including lung cancer, in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix * Current lung cancer is known to be stage III or IV by pathology. Inclusion Criteria - Screening: \- Current or past smokers, with at least 20 pack-years, undergoing LDCT for lung cancer screening Exclusion Criteria - Screening: * Known diagnosis or treatment of any cancer, including lung cancer, in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix * Subjects whose purpose of performing LDCT is for surveillance of a lung nodule
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Scripps Memorial HospitalEncinitas, California
- Centura HealthLakewood, Colorado
- VA Connecticut Healthcare SystemWest Haven, Connecticut
- Orlando Health, Inc.Orlando, Florida
- Sarasota Memorial HospitalSarasota, Florida
- St. Elizabeth Edgewood HospitalEdgewood, Kentucky
- Norton Cancer InstituteLouisville, Kentucky
- Owensboro HealthOwensboro, Kentucky
- Johns Hopkins Medical CenterBaltimore, Maryland
- Lahey Hospital and Medical CenterBurlington, Massachusetts
- University of Minnesota HealthMinneapolis, Minnesota
- Harry S. Truman Memorial Veterans' HospitalColumbia, Missouri
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 4, 2025. Always confirm current availability with the study team.